ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges.

ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges. Br J Cancer. 2022 02; 126(2):174-186.

View in: PubMed